AN2 Therapeutics, Inc. (ANTX)
NASDAQ·Healthcare·Biotechnology
$4.76
+6.85%
Mkt Cap $131.53M
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$9.00
Range $9.00 – $9.00
Implied Upside
+89.3%
Consensus $9.00 vs current $4.76
NASDAQ·Healthcare·Biotechnology
$4.76
+6.85%
Mkt Cap $131.53M
No recent rating data.
Price Target (8 analysts)
$9.00
Range $9.00 – $9.00
+89.3%
Consensus $9.00 vs current $4.76